Search Results 41-50 of 14734 for ������������������������������������������r���:PC53���

  1. Overview - Immunometabolism and Cancer Immunology Laboratory - Mayo Clinic Research

    The Immunometabolism and Cancer Immunology Lab of Marion R. Curtis, Ph.D., at Mayo Clinic studies the tumor microenvironment for ovarian cancer ...

  2. Paul R. Daniels, M.D. - Mayo Clinic Faculty Profiles

    Paul R. Daniels, M.D.. Location. Rochester, Minnesota Clinical Profile. PROFESSIONAL DETAILS. Primary Appointment. Consultant, Division of Vascular Cardiology ...

  3. A Study Evaluating KTE-X19 in Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (r/r ALL) (ZUMA-3) - Mayo Clinic

    Clinical Trials · A Study Evaluating KTE-X19 in Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (r/r ALL) (ZUMA-3) · More about ...

  4. R. Paul Boesch, D.O. - Doctors and Medical Staff - Mayo Clinic

    Pediatric bronchology · Pediatric airway disease and aerodigestive disorders · Pulmonary aspiration · Chronic mechanical ventilation · Thoracic insufficiency and ...

  5. Mayo Clinic Comprehensive Cancer Center — Research

    Targeted drug therapies have greatly improved outcomes for patients with relapsed or refractory (R/R) chronic lymphocytic leukemia (CLL) and non-Hodgkin's ...

  6. Lewis R. Roberts, M.B., Ch.B., Ph.D.

    1998. ResidentGastroenterology, Programs in Rochester, Mayo School of Graduate Medical Education, Mayo Clinic College of Medicine · 1998. Clinician Investigator ...

  7. Mayo Clinic Laboratories.

  8. Daniel R. Brown, M.D., Ph.D. - Mayo Clinic Faculty Profiles

    Mayo Clinic researcher Daniel R. Brown, M.D., Ph.D., focuses his nonclinical time on hospital administration and the transformation of healthcare delivery ...

  9. Avelumab In Combination Regimens That Include An Immune Agonist, Epigenetic Modulator, CD20 Antagonist and/or Conventional Chemotherapy in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL) - Mayo Clinic

    ... (R/R DLBCL). Print details. Share; Facebook · Twitter. Overview; Participation ... (R/R) Diffuse Large B-Cell Lymphoma (DLBCL). Participation eligibility.

  10. Compare the Efficacy and Safety of Golcadomide Plus R-CHOP vs Placebo Plus RCHOP in Participants with Previously Untreated High-risk Large B-cell Lymphoma - Mayo Clinic

    The purpose of this study is to evaluate the efficacy of golcadomide plus R-CHOP vs placebo-R-CHOP in participants with untreated high-risk large B-cell ...